1.Effectiveness of Montelukast in Reducing the Risk of Severe Dengue in Dengue Fever Patients: An Evidence-Based Case Report
Nicholas Jason Wijaya ; Sharifah Shakinah ; Leonard Nainggolan ; Erni Juwita Nelwan
Acta Medica Indonesiana 2026;58(1):115-122
Abstract
Background: Dengue fever continues to spread worldwide, particularly in tropical regions. Some patients with dengue fever may progress to severe dengue, which is associated with significantly higher morbidity and mortality. Despite this, no definitive treatment has been found to prevent its progression. Montelukast, a leukotriene receptor antagonist, has shown potential in reducing plasma leakage, a key factor in the pathophysiology of severe dengue. Therefore, this study aimed to evaluate the effectiveness of montelukast in reducing the risk of severe dengue. Methods: A systematic literature search was conducted on April 16, 2025, using keywords related to montelukast and dengue across four databases, which included PubMed, Taylor and Francis, Cochrane Library, and ScienceDirect. A critical appraisal was performed using the Oxford Centre for Evidence-Based Medicine framework, evaluating the validity, importance, and applicability of each study. The primary outcomes were the incidence of dengue shock syndrome and dengue with warning signs. The secondary outcomes included mortality rate and hospitalization duration. Results: This study included three studies involving a total of 1057 patients. Montelukast is associated with a reduced incidence of dengue shock syndrome and shorter duration of hospitalization. However, the effect of montelukast on dengue with warning signs and mortality rate was inconclusive. Conclusion: Montelukast shows potential as an adjuvant therapy in preventing the progression of dengue fever to severe dengue. However, further research is required before montelukast can be widely recommended for dengue fever patients in daily clinical practice and possibly integrated into dengue fever clinical guidelines.
evidence-based case report
;
severe dengue
;
dengue fever
;
leukotriene receptor antagonist
;
montelukast
2.When Thyroid Meets Dengue and Hepatitis: A Case of Severe Thyrotoxicosis with Multiorgan Dysfunction
Shamila Sutharsan ; Yusniza Yusoff
Journal of the ASEAN Federation of Endocrine Societies 2026;41(S1):112-113
Introduction:
Severe thyrotoxicosis is an endocrine emergency that
may present with multiorgan dysfunction, particularly
when precipitated by systemic infection. Management
becomes challenging when hepatic injury limits the use of
standard antithyroid therapy. We report a case of severe
thyrotoxicosis with acute hepatitis in the setting of dengue
IgM positivity.
Case:
A 44-year-old male with chronic alcohol use presented with
epistaxis. On examination, he was deeply jaundiced and
had tremors on outstretched hands. Initial investigations
showed severe hepatitis with AST 2029 U/L, ALT 698 U/L,
total bilirubin 236 µmol/L, alkaline phosphatase 138 U/L,
and thrombocytopenia (34 ×10⁹/L). Viral hepatitis HBV,
HCV, HIV, and autoimmune hepatitis screen were negative.
Dengue IgM was positive.
Thyroid function tests demonstrated overt thyrotoxicosis
with free thyroxine 4 (FT4) 58.6 pmol/L and suppressed
thyroid-stimulating hormone.
He was managed as severe thyrotoxicosis with impending
thyroid crisis in view of systemic illness and multiorgan
involvement. Due to significant hepatic dysfunction, he
was treated with propranolol, dexamethasone, and lithium
carbonate 300 mg BD. Over 5 days, there was marked
clinical improvement with resolution of tachycardia and
tremors. FT4 decreased to 44.8 pmol/L. Liver function
tests improved significantly (AST 157 U/L, ALT 195 U/L,
bilirubin 163 µmol/L), and thrombocytopenia resolved
(platelets 323 ×10⁹/L). He remained hemodynamically stable
with normal Glasgow Coma Scale throughout admission.
Conclusion
This case highlights severe thyrotoxicosis with acute
hepatitis and dengue infection, where management
was complicated by contraindication to conventional
antithyroid therapy. Lithium and corticosteroids provided
effective biochemical and clinical improvement. Early
recognition and individualized therapy are crucial in
complex multisystem thyrotoxic presentations.
Hepatitis A
;
Thyrotoxicosis
;
Dengue
3.Determinants of delayed consultation in pediatric dengue: A cross-sectional study in Batangas, Philippines
Marcia Angelica L. Ricalde ; Daisy O. Sanchez-Mosterio
Pediatric Infectious Disease Society of the Philippines Journal 2025;26(1):30-42
OBJECTIVE
Dengue remains a critical public health concern in the Philippines. Late consultation and delayed presentation of dengue patients to hospitals constantly challenge doctors. This study aimed to identify factors contributing to late consultation of dengue patients.
METHODOLOGYThis analytic, cross-sectional study examined patient, parental, socioeconomic, cultural, and health system factors influencing delayed consultation among parents of patients 0 – 18 years at Batangas Medical Center and Lipa Medix Medical Center. A total of 668 parents were enrolled. Descriptive statistics and frequency tables summarized the key characteristics. Test of proportions assessed differences between groups. Univariate logistic regression screened possible predictors, followed by multiple logistic regression to identify significant factors.
RESULTSUnivariate analysis identified significant predictors of late consultation, including older patient age(p=0.002), residence >50 km from the hospital (p 50 km from the hospital were 2.7 times more likely to consult late (p=0.01).
CONCLUSIONDelayed consultation was influenced by the patient age, hospital type, geographic distance from the hospital, maternal marital status, and cultural beliefs in home remedies and faith healing. Strategies to improve early consultation should consider these factors.
Human ; Dengue ; Health-seeking Behavior ; Health Behavior ; Cross-sectional Studies
4.Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as early predictive markers of dengue severity in pediatric patients: A retrospective analysis
Angela Marie D. Jimenez ; Janella M. Tiu
Pediatric Infectious Disease Society of the Philippines Journal 2025;26(1):43-52
OBJECTIVE
To determine whether neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) within the first three days of dengue illness are independent predictors of dengue severity among pediatric patients.
METHODOLOGYA cross-sectional analytical retrospective study was conducted among pediatric dengue patients admitted to The Medical City, Pasig from September 2021 to August 2024. Data collection was done through electronic chart review. Baseline characteristics were analyzed using the Kruskal-Wallis test, Chi-Square test, and Fisher’s exact test. Receiver Operating Characteristic (ROC) and Area Under the Curve (AUC) analyses, along with diagnostic performance metrics, were used to evaluate daily ratio cut-offs differentiating dengue classifications. Multivariable logistic regression was performed to assess NLR and PLR as independent predictors of warning signs or severe dengue development.
RESULTSAmong the 316 subjects included in the analysis, 40.5% had dengue fever without warning signs, 57.3% had dengue fever with warning signs, and 2.2% had severe dengue. Differentiating patients without warning signs from those with warning signs, the NLR cut-offs were 4.73, 2.07, and 2.5 on days 1-3, respectively, whereas from those with severe dengue, the cut-offs were 1.27, 0.68, and 0.47 on the same days. For this pairwise analysis, PLR cut-offs were 170, 233.92, and 208.79 for the first comparison; and 209.24, 244.12, and 187.5 for the second, respectively. Statistical analysis showed poor discrimination and diagnostic performance for all cut-offs. Likewise, multivariable linear regression revealed no significant correlation between either ratio and dengue severity.
CONCLUSIONNLR and PLR within the first three days of dengue illness revealed poor performance in predicting the development of warning signs or progression to severe dengue among pediatric patients.
Human ; Dengue Fever ; Dengue
6.Expert consensus on the diagnosis, treatment, and prevention of neonatal dengue, chikungunya, and Zika virus infections (2025).
Chinese Journal of Contemporary Pediatrics 2025;27(10):1155-1166
Mosquito-borne viruses, including dengue virus (DENV), chikungunya virus (CHIKV), and Zika virus (ZIKV), pose major threats to public health in tropical and subtropical regions worldwide. Neonates are particularly vulnerable, and the associated disease burden has drawn increasing attention. Routes of neonatal infection include vertical mother-to-child transmission (transplacental and peripartum) and postnatal mosquito bites. Clinical manifestations are often nonspecific; a proportion of cases may progress to central nervous system infection, hemorrhagic disease, or long-term neurodevelopmental impairment, with serious consequences for survival and quality of life. Although China has issued prevention and control guidelines for adults and pregnant women, systematic clinical guidance tailored to neonates remains lacking. In response, the Perinatal Group of the Pediatric Branch of the Chinese Medical Doctor Association convened a multidisciplinary panel to develop this expert consensus, integrating the latest international evidence with China's practical prevention and control experience. The consensus addresses epidemiology; the effects of maternal infection on fetuses and neonates; clinical manifestations; diagnosis and differential diagnosis; early warning indicators of severe disease; therapeutic strategies and supportive care; and prevention and maternal-infant management. It aims to provide evidence-based, standardized, and practical guidance for frontline clinicians managing neonatal mosquito-borne viral infections.
Humans
;
Zika Virus Infection/therapy*
;
Infant, Newborn
;
Chikungunya Fever/therapy*
;
Dengue/prevention & control*
;
Female
;
Pregnancy
;
Consensus
7.Concurrent late post-tonsillectomy hemorrhage and dengue fever in a 17-Year-old girl: A case report
Josephine Grace R. Tan ; Rachel Zita H. Ramos
Philippine Journal of Otolaryngology Head and Neck Surgery 2025;40(Supplement):21-23
OBJECTIVE
To present the case of a 17-year-old girl who was readmitted post-tonsillectomy due to dengue fever, hematemesis and late tonsillar bleeding three weeks after the surgery.
METHODSDesign:Case Report
Setting:Tertiary Government Training Hospital
Patient: One
RESULTSA previously healthy 17-year-old Filipino girl underwent uncomplicated elective tonsillectomy for chronic hypertrophic tonsillitis. Twenty days post-operatively, she developed fever, thrombocytopenia and massive hematemesis. Despite intensive care management for severe dengue fever with concurrent late post-tonsillectomy bleeding, the patient died from hemorrhagic shock on post-operative day 21.
CONCLUSIONThis appears to be the first reported case of concurrent late post-tonsillectomy hemorrhage and dengue fever in a previously healthy adolescent girl. In dengue-endemic areas, post-tonsillectomy patients should be counseled about dengue prevention and advised to seek medical attention for persistent fever. Early recognition and management of this potentially fatal combination is crucial for improving patient outcomes.
Human ; Female ; Adolescent: 13-18 Yrs Old ; Tonsillectomy ; Mortality ; Dengue ; Severe Dengue ; Dengue Hemorrhagic Fever
8.Dengue-associated neuroretinitis: A case report
Minnette G. Dagta ; Adrian P. Bautista ; Erwin D. Palisoc
Philippine Journal of Ophthalmology 2025;50(2):99-102
OBJECTIVE
To describe a case of dengue-associated bilateral neuroretinitis in a young female adult.
METHODSThis is a case report.
RESULTSA 25-year-old female was referred for evaluation of bilateral blurring of vision during the convalescent stage of dengue fever. Visual acuity was 20/80 in each eye. Fundoscopy showed mild optic disc swelling, macular thickening, and hard exudates bilaterally. Dengue-associated neuroretinitis was considered. Intravenous methylprednisolone treatment for three days resulted in significant improvements in visual function and resolution of fundus abnormalities.
CONCLUSIONDengue is a potential etiology of neuroretinitis in endemic areas, especially in those who develop visual symptoms during the convalescent phase. Prompt recognition and treatment may prevent long-term visual impairment.
Human ; Female ; Adult: 25-44 Yrs Old ; Dengue Fever ; Dengue ; Neuroretinitis ; Retinitis ; Methylprednisolone
9.Targets and mechanisms of neutralizing monoclonal antibodies against Dengue virus.
Zheng CHENG ; Jinghua YAN ; Xiaonan HAN
Chinese Journal of Biotechnology 2024;40(12):4311-4323
Dengue fever is a mosquito-borne disease prevalent in tropical and subtropical regions, with its prevalence expanding due to increased global travel. The dengue virus, the causative agent of dengue fever, often co-circulates in the form of four distinct serotypes. Cross-reactive antibodies generated during a primary infection pose a significant risk during secondary infections with different serotypes, and fully protective vaccines and antiviral drugs are yet to be developed. Over the past decade, advances in antibody technology have led to the isolation of numerous monoclonal antibodies against dengue virus, with their neutralizing epitopes elucidated through structure-based analyses. This review highlights the key epitopes associated with neutralizing antibodies against dengue virus and discusses their potential applications in vaccine design and therapeutic antibody development. This review helps systematically summarize the progress in dengue virus neutralizing antibody research, providing a theoretical foundation and technical guidance for the development of novel vaccines and antibody therapeutics.
Dengue Virus/immunology*
;
Antibodies, Neutralizing/immunology*
;
Antibodies, Monoclonal/therapeutic use*
;
Dengue/prevention & control*
;
Humans
;
Antibodies, Viral/immunology*
;
Epitopes/immunology*
;
Animals
;
Dengue Vaccines/immunology*
10.Rehabilitation management of a patient with median nerve entrapment from venipuncture-associated hematoma in dengue hemorrhagic fever: A case report
Jeffrey S. Arboleda ; Joycie Eulah H. Abiera ; Khariz S. Anarna
Acta Medica Philippina 2024;58(20):121-126
Dengue hemorrhagic fever is a severe form of dengue presenting commonly with bleeding diathesis, but rarely with peripheral nervous system manifestations. Proximal median neuropathy comprises 1% of upper limb compression syndromes, and this case is the first to report injury to the proximal median nerve due to compression from hematoma formation. This case report presents the rehabilitation process of a 25-year-old Filipino female median nerve entrapment from venipuncture-associated hematoma presenting as burning sensation on the medial elbow, forearm and hand, weak flexion movement of her left thumb, index, and middle fingers. The patient was managed conservatively with pain medications, range of motion, gross and fine motor, and sensory re-education exercises. At 12 months, there was partial but functional recovery of median motor distribution and full recovery of median sensory distribution, as evidenced by improved sensory nerve action potential conduction velocity and amplitude, and compound motor action potential conduction velocity, with persistent decreased amplitude at 50%, and decrease in cross-sectional area of the left median nerve.
This paper highlights the functional outcomes of a conservatively managed median nerve entrapment from venipuncture hematoma from dengue hemorrhagic fever. This case report also emphasizes that in the presence of severe bleeding risk of surgery in the background of severe thrombocytopenia, timely rehabilitation medicine referral with monitoring through clinical evaluation, musculoskeletal ultrasound, and electrodiagnostic study presents a viable alternative in the management of compression neuropathy.
Dengue Hemorrhagic Fever ; Severe Dengue ; Nerve Conduction Studies ; Rehabilitation


Result Analysis
Print
Save
E-mail